Blood cancers, Myeloma
Results
Phase 2
This study looked at bortezomib for people with myeloma after they have had a transplant of their own stem cells.
An is one using your own stem cells. Doctors might refer to this as intensive treatment.
This trial was open for people to join between 2009 and 2014. These results were published in 2018.
Recruitment start: 2 December 2009
Recruitment end: 27 March 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Kwee Young
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University College London (UCL)
Janssen-Cilag
Last reviewed: 15 September 2024
CRUK internal database number: 6502
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
